Targeting lipophilic cations to mitochondria

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1777, Issue 7-8, 2008, Pages 1028-1031

  Murphy, Michael P ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Antioxidant; Mitochondria; MitoQ; Oxidative damage

Indexed keywords

ANTIOXIDANT; CATION; EBSELEN; FLAVOPROTEIN; HYDROGEN PEROXIDE; MITOE; MITOQ; PHOSPHONIUM DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SUPEROXIDE; THIOCTIC ACID; TOCOPHEROL; UBIQUINONE; UBIQUINONE DERIVATIVE;

ANTIOXIDANT ACTIVITY; BIOLOGICAL ACTIVITY; CELL DEATH; CELL FUNCTION; CELL PROTECTION; CELLULAR DISTRIBUTION; CONJUGATION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; IN VIVO STUDY; LIPID PEROXIDATION; LIPOPHILICITY; MEDICAL RESEARCH; MEMBRANE TRANSPORT; MITOC?ONDRIAL RESPIRATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOLECULAR PROBE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SPIN TRAPPING; TARGET CELL;

ADENOSINE TRIPHOSPHATE; ANTIOXIDANTS; CATIONS; CELL PHYSIOLOGY; CYTOPLASM; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; ORGANOPHOSPHORUS COMPOUNDS;

EID: 46349110018     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2008.03.029     Document Type: Review

References (26)

1. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7915-7922
2. Beckman K.B., and Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78 (1998) 547-581
3. Green K., Brand M.D., and Murphy M.P. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 53 (2004) S110-S118
4. Finkel T. Opinion: radical medicine: treating ageing to cure disease. Nat. Rev., Mol. Cell Biol. 6 (2005) 971-976
5. Murphy M.P. Targeting bioactive compounds to mitochondria. Trends Biotechnol. 15 (1997) 326-330
6. Murphy M.P. Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction. Expert Opin. Biol. Ther. 1 (2001) 753-764
7. Murphy M.P., and Smith R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 629-656
8. Liberman E.A., Topali V.P., Tsofina L.M., Jasaitis A.A., and Skulachev V.P. Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature 222 (1969) 1076-1078
9. Azzone G.F., Pietrobon D., and Zoratti M. Determination of the proton electrochemical gradient across biological membranes. Curr. Topics Bioenerg. 13 (1984) 1-77
10. Ross M.F., Kelso G.F., Blaikie F.H., James A.M., Cochemé H.M., Filipovska A., Da Ros T., Hurd T.R., Smith R.A., and Murphy M.P. Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry (Moscow) 70 (2005) 222-230
11. Ross M.F., Da Ros T., Blaikie F.H., Prime T.A., Porteous C.M., Severina I.I., Skulachev V.P., Kjaergaard H.G., Smith R.A., and Murphy M.P. Accumulation of lipophilic dications by mitochondria and cells. Biochem. J. 400 (2006) 199-208
12. James A.M., Sharpley M.S., Manas A.R., Frerman F.E., Hirst J., Smith R.A., and Murphy M.P. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J. Biol. Chem. 282 (2007) 14708-14718
13. James A.M., Cochemé H.M., Smith R.A., and Murphy M.P. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J. Biol. Chem. 280 (2005) 21295-21312
14. Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., Smith R.A.J., and Murphy M.P. Selective targeting of a redox-active ubiquinone to mitochondria within cells. J. Biol. Chem. 276 (2001) 4588-4596
15. Asin-Cayuela J., Manas A.R., James A.M., Smith R.A., and Murphy M.P. Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett. 571 (2004) 9-16
16. Smith R.A.J., Porteous C.M., Coulter C.V., and Murphy M.P. Targeting an antioxidant to mitochondria. Eur. J. Biochem. 263 (1999) 709-716
17. Brown S.E., Ross M.F., Sanjuan-Pla A., Manas A.R., Smith R.A., and Murphy M.P. Targeting lipoic acid to mitochondria: synthesis and characterization of a triphenylphosphonium-conjugated alpha-lipoyl derivative. Free Radic. Biol. Med. 42 (2007) 1766-1780
18. Murphy M.P., Echtay K.S., Blaikie F.H., Asin-Cayuela J., Cochemé H.M., Green K., Buckingham J.A., Taylor E.R., Hurrell F., Hughes G., Miwa S., Cooper C.E., Svistunenko D.A., Smith R.A., and Brand M.D. Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J. Biol. Chem. 278 (2003) 48534-48545
19. Filipovska A., Kelso G.F., Brown S.E., Beer S.M., Smith R.A., and Murphy M.P. Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic: insights into the interaction of ebselen with mitochondria. J. Biol. Chem. (2005)
20. Lin T.K., Hughes G., Muratovska A., Blaikie F.H., Brookes P.S., Darley-Usmar V., Smith R.A.J., and Murphy M.P. Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach. J. Biol. Chem. 277 (2002) 17048-17056
21. Jauslin M.L., Meier T., Smith R.A.J., and Murphy M.P. Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J. 17 (2003) 1972-1974
22. -P-mediated mitochondrial outgrowth. Am. J. Physiol., Cell Physiol. 288 (2005) C1440-C1450
23. Smith R.A.J., Porteous C.M., Gane A.M., and Murphy M.P. Delivery of bioactive molecules to mitochondria in vivo. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5407-5412
24. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A., Murphy M.P., and Sammut I.A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 19 (2005) 1088-1095
25. Esplugues J.V., Rocha M., Nunez C., Bosca I., Ibiza S., Herance J.R., Ortega A., Serrador J.M., D'Ocon P., and Victor V.M. Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ. Res. 99 (2006) 1067-1075
26. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23 (1997) 3-25